PILL ETF — Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL)

Updated October 16, 2026.

PILL is an ETF linked to Pharmaceutical & Medical. its distribution rate is 0.03%, its trailing-12-month yield is 0.44%, its expense ratio is 0.98%. Dividend Vision Distribution Safety Score™ is 12/100 (High risk). Total return is -39.0% over the past 8.9 years, 280.6 points behind SPY at 241.6%.

This ETF seeks to deliver three times the daily performance of pharmaceutical and medical stocks from the S&P Total Market Index classified in the pharmaceuticals sub-industry. It carries a modest distribution rate with quarterly distributions and an expense ratio of 0.98%; the fund employs leverage to amplify daily price movements and is non-diversified. This leveraged product appeals primarily to experienced traders seeking short-term directional exposure to the pharmaceutical sector rather than buy-and-hold investors, as daily rebalancing compounds returns and losses over time.

PILL performance versus SPY

Price and return data through 2026-10-16.

Total return is -39.0% over the past 8.9 years, 280.6 points behind SPY at 241.6%. Over the past year its total return — price change plus distributions reinvested — is 66.9%. Its deepest 1-year drawdown was 43.8%.

PILL key facts

Distribution Safety Score™

12 · High risk

Safety-Adjusted Yield

0.00%

Issuer

Direxion

Asset type

ETF

Asset class

Equity

Inception date

11/15/2017

Expense ratio

0.98%

Distribution rate

0.03%

Distribution frequency

Quarterly

Trailing yield

0.44%

Last close

$13.41 (as of 2026-10-16)

AUM

$17,034,835

Average volume

73243.0

Dividend

$0.001

Ex-dividend date

09/22/2026

Payment date

09/29/2026

Beta

1.71

How Dividend Vision calculates yield and returns

Distribution rate (0.03%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (0.44%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: Direxion; Index: Pharmaceutical & Medical; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

PILL risks and drawbacks

PILL's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 43.8%.

Who may consider PILL — and who may not

It is a weaker fit for investors who need monthly cash flow (PILL pays quarterly); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on PILL

• All tickers starting with P

Tagged: Leverage.

Frequently asked questions

More securities from Direxion.